The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for M Schröder


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structure-kinetic relationship reveals the mechanism of selectivity of FAK inhibitors over PYK2.EBI
Goethe University Frankfurt
Discovery of Ligands for TRIM58, a Novel Tissue-Selective E3 Ligase.EBI
Novartis Institutes for Biomedical Research
Discovery of New Binders for DCAF1, an Emerging Ligase Target in the Targeted Protein Degradation Field.EBI
Novartis Institutes for Biomedical Research
MSC-1186, a Highly Selective Pan-SRPK Inhibitor Based on an Exceptionally Decorated Benzimidazole-Pyrimidine Core.EBI
Goethe University Frankfurt
Development of a Selective Dual Discoidin Domain Receptor (DDR)/p38 Kinase Chemical Probe.EBI
Johann Wolfgang Goethe University
Demonstrating Ligandability of the LC3A and LC3B Adapter Interface.EBI
Goethe-University Frankfurt
Design and Development of a Chemical Probe for Pseudokinase CaEBI
Goethe University Frankfurt Am Main
DFG-1 Residue Controls Inhibitor Binding Mode and Affinity, Providing a Basis for Rational Design of Kinase Inhibitor Selectivity.EBI
Goethe-University Frankfurt
An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases.EBI
University of Oxford
Selective targeting of the αC and DFG-out pocket in p38 MAPK.EBI
Johann Wolfgang Goethe University
New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis.EBI
University of Clermont Auvergne
Fast Iterative Synthetic Approach toward Identification of Novel Highly Selective p38 MAP Kinase Inhibitors.EBI
Johann Wolfgang Goethe-University